{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T12:32:31Z","timestamp":1722083551795},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T00:00:00Z","timestamp":1410998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107234","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T14:10:11Z","timestamp":1411049411000},"page":"e107234","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer"],"prefix":"10.1371","volume":"9","author":[{"given":"Kenji","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadanori","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kajihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ichiro","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniko","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Oosaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jjco\/hyi185","article-title":"Comparison of prostate cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960\u20132000)","volume":"35","author":"T Marugame","year":"2005","journal-title":"Jpn J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-2042.2009.02293.x","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives","volume":"16","author":"K Ito","year":"2009","journal-title":"Int J Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"WJ Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/jnci\/90.16.1230","article-title":"Prostate cancer incidence and mortality in the United States and the United Kingdom","volume":"90","author":"A Shibata","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM200105033441806","article-title":"Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer","volume":"344","author":"MJ Barry","year":"2001","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.6004\/jnccn.2010.0017","article-title":"Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values","volume":"8","author":"WJ Catalona","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-149-3-200808050-00009","article-title":"Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force","volume":"149","author":"K Lin","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/pros.20545","article-title":"The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC)","volume":"67","author":"MJ Roobol","year":"2007","journal-title":"Prostate"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","article-title":"Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges","volume":"270","author":"JE Oesterling","year":"1993","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.ejca.2007.06.006","article-title":"PSA and other tissue kallikreins for prostate cancer detection","volume":"43","author":"C Stephan","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrurol.2010.41","article-title":"Prostate cancer: utility of the risk indicator model in screening","volume":"7","author":"S Loeb","year":"2010","journal-title":"Nat Rev Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3122\/jabfm.16.2.95","article-title":"Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma","volume":"16","author":"K Mistry","year":"2003","journal-title":"J Am Board Fam Pract"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bjc.6603246","article-title":"Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia","volume":"95","author":"N Pashayan","year":"2006","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"94","author":"R Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref16","first-page":"CD004720","article-title":"Screening for prostate cancer. Cochrane Database Syst Rev","volume":"1","author":"D Ilic","year":"2013"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"GL Andriole","year":"2009","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00345-007-0203-6","article-title":"Biomarkers for prostate cancer","volume":"25","author":"E Schiffer","year":"2007","journal-title":"World J Urol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jprot.2009.01.007","article-title":"Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease","volume":"72","author":"RR Drake","year":"2009","journal-title":"J Proteomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatter plots","volume":"74","author":"WS Cleveland","year":"1979","journal-title":"J Amer Statist Assoc"},{"key":"ref21","first-page":"229","article-title":"Signal background estimation and baseline correction algorithms for accurate DNA Sequencing","volume":"35","author":"L Andrade","year":"2003","journal-title":"Journal of VLSI, Special issue on Bioinformatics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1002\/pmic.200401261","article-title":"Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform","volume":"5","author":"KR Coombes","year":"2005","journal-title":"Proteomics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1093\/bioinformatics\/bti482","article-title":"Algorithms for alignment of mass spectrometry proteomic data","volume":"21","author":"N Jeffries","year":"2005","journal-title":"Bioinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cem.1006","article-title":"OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification","volume":"20","author":"M Bylesj\u00f6","year":"2006","journal-title":"J Chemometrics"},{"key":"ref25","unstructured":"Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstr\u00f6m C, et al. (2006) Multi- and Megavariate Data Analysis Part 2: Advanced Applications and Method Extensions. 2nd ed., Umetrics Academy, Umetrics AB, Sweden."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cca.2011.02.029","article-title":"The measurement of a fibrinogen \u03b1 C-chain 5.9 kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution","volume":"412","author":"K Sogawa","year":"2011","journal-title":"Clin Chim Acta"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2012.10.014","article-title":"Utilizing isotope dilution-matrix-assisted laser desorption ionization-time of flight mass spectrometry as a reference procedure for the radioimmunoassay of serum thyroxine","volume":"420","author":"YC Tyan","year":"2013","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"T Fawcett","year":"2006","journal-title":"Pattern Recogn Lett"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2423(10)51006-0","article-title":"Advances in pancreatic cancer detection","volume":"51","author":"CP Tanase","year":"2010","journal-title":"Adv Clin Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1582-4934.2008.00250.x","article-title":"Applications of SELDI-MS technology in oncology","volume":"12","author":"LC Whelan","year":"2008","journal-title":"J Cell Mol Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/erm.09.52","article-title":"Serum proteomics of glioma: methods and applications","volume":"9","author":"K Somasundaram","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.20097","article-title":"Cancer mortality in Europe, 1995\u20131999, and an overview of trends since 1960","volume":"110","author":"F Levi","year":"2004","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/pcan.2008.2","article-title":"Beyond prostate-specific antigen: alternate serum markers","volume":"11","author":"ML Ramirez","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnci\/djp001","article-title":"Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context","volume":"101","author":"G Draisma","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/jnci\/djn368","article-title":"Prostate-specific antigen: a misused and maligned prostate cancer biomarker","volume":"100","author":"IM Thompson","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/djp043","article-title":"Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker","volume":"101","author":"RJ Hamilton","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.ju.0000137659.53129.14","article-title":"Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein","volume":"172","author":"CG Rogers","year":"2004","journal-title":"J Urol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1098-2388(200001\/02)18:1<10::AID-SSU3>3.0.CO;2-V","article-title":"Prostate-specific membrane antigen (PSMA): current benefits and future value","volume":"18","author":"AA Elgamal","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1464-410X.2008.08280.x","article-title":"Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)","volume":"103","author":"RS Kirby","year":"2009","journal-title":"BJU Int"},{"key":"ref40","first-page":"191","article-title":"Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer","volume":"33","author":"E Dimitriadis","year":"2013","journal-title":"Anticancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4172\/1948-5956.1000119","article-title":"TMPRSS2-ERG fusion gene expression in prostate tumor cells and its clinical and biological significance in prostate cancer progression","volume":"4","author":"J St John","year":"2012","journal-title":"J Cancer Sci Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/pros.22563","article-title":"Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer","volume":"73","author":"JN Cornu","year":"2012","journal-title":"Prostate"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1074\/mcp.M800095-MCP200","article-title":"Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach","volume":"7","author":"D Xu","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1039\/b904701h","article-title":"Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B\/MMP-9 substrates","volume":"1","author":"B Cauwe","year":"2009","journal-title":"Integr Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1096\/fj.12-205229","article-title":"Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment","volume":"26","author":"V Laurent-Matha","year":"2012","journal-title":"FASEB J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbamcr.2009.09.015","article-title":"Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics","volume":"1803","author":"D Rodr\u00edguez","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10555-006-7890-0","article-title":"Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer","volume":"25","author":"CM Overall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mam.2008.04.003","article-title":"Protease proteomics: revealing protease in vivo functions using systems biology approaches","volume":"29","author":"A Doucet","year":"2008","journal-title":"Mol Aspects Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:42:44Z","timestamp":1565829764000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107234"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Culig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,18]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107234","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,18]]}}}